title: Medical relevance of UK-funded non-human primate research published from January 1997 to July 2012.
abstract: In 2012, the Bateson Review of research using non-human primates (NHPs) recommended the commissioning of a working group to identify and follow-up the results of UK-funded NHP research of potential benefit for human health (Recommendation 4), but the Medical Research Council (MRC) has postponed implementation of the recommendation. Information on results and potential benefits of NHP research therefore remains unavailable. To fill this gap in knowledge, this study identified all published NHP research studies funded by the MRC, Wellcome Trust and Biotechnology and Biological Sciences Research Council (BBSRC) from January 1997 to July 2012 and assessed full texts for medical relevance. In total, 284 papers were identified, of which 51 (18%) involved invasive NHP research, compared to 176 (61%) which used NHP tissue and cell lines, indicating a shift in research emphasis from invasive whole animal to cell-based research. Of these studies, 98 (35%) were medically relevant, of which 22 had potential therapeutic or public health applications. The relatively low proportion of medical studies together with the small number of applied studies raises questions over the level of investment in medical research and the effectiveness of knowledge transfer from basic to applied research. Implementation of the Bateson Review's Recommendation 4 would address these questions.
authors.affiliation: Claremount, 9 Porterfield Road, Inverness IV2 3HW, UK e.moore157@btinternet.com.
authors.forename: Edward
authors.initials: E
authors.lastname: Moore
keywords: medical; non-human; primate; published; relevance; research
references.citation: AIDS. 2010 Oct;24 Suppl 4:S50-60
references.pmid: 21042053
references.citation: Nature. 2010 Sep 23;467(7314):420-5
references.pmid: 20864995
references.citation: Genome Biol. 2010 Jan 26;11(1):201
references.pmid: 20122293
references.citation: Br J Neurosurg. 2008;22 Suppl 1:S41-4
references.pmid: 19085352
references.citation: BMC Evol Biol. 2008 Oct 06;8:273
references.pmid: 18837980
references.citation: Hum Mol Genet. 2008 Jan 15;17(2):170-8
references.pmid: 17921520
references.citation: Genome Biol. 2009;10(9):R102
references.pmid: 19781061
references.citation: J Gen Virol. 2008 Nov;89(Pt 11):2843-2850
references.pmid: 18931082
references.citation: Hum Mol Genet. 2006 Jan 1;15(1):23-31
references.pmid: 16311254
references.citation: J Appl Microbiol. 2011 Dec;111(6):1505-14
references.pmid: 21920003
references.citation: Gene Ther. 1998 Aug;5(8):1137-47
references.pmid: 10326038
references.citation: Trends Parasitol. 2009 Sep;25(9):423-31
references.pmid: 19717340
references.citation: Hum Mol Genet. 2010 Sep 1;19(17):3413-29
references.pmid: 20566712
references.citation: Cell Death Dis. 2010;1:e106
references.pmid: 21218173
references.citation: BMC Immunol. 2010 Mar 18;11:13
references.pmid: 20298574
references.citation: Trans R Soc Trop Med Hyg. 2007 Nov;101(11):1061-2
references.pmid: 17548098
references.citation: Endocr Relat Cancer. 2009 Dec;16(4):1157-69
references.pmid: 19635783
references.citation: Microbiology (Reading). 2006 Sep;152(Pt 9):2573-2578
references.pmid: 16946252
references.citation: J Cell Sci. 2008 May 15;121(Pt 10):1649-60
references.pmid: 18430781
references.citation: Nature. 2008 Nov 6;456(7218):60-5
references.pmid: 18987735
references.citation: Trends Parasitol. 2005 Jul;21(7):299-301
references.pmid: 15923144
references.citation: Thorax. 2011 Dec;66(12):1029-35
references.pmid: 21606476